Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype
Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype have?
Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype has 142 citations in the OpenAlex counts ScholarIQ stores.
When was Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype published?
Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype has 2011 year in the ScholarIQ index.
What is the open-access status of Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype?
Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype has closed oa status in the ScholarIQ index.
What is the DOI of Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype?
The DOI for Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype is on the source record.
What is the PMID of Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype?
The PMID for Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype is on the source record.
What is the OpenAlex record for Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype?
The OpenAlex for Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype is on the source record.